Replies to post #3508 on Navidea Biopharmaceuticals Inc (NAVB)

[sts66]

This is huge - sentinel node designation for solid tumors - no diagnostic has ever had that label, ever - and the market reaction? A large collective snore....or the shorts are still in control....based on that data release and the rec to cut short the study as it's unfair to the control group patients (another great piece of news), plus the start of the Alzheimer's trial enrollment, has convinced me to buy one more lot of this....I strongly suspect the shorts/MM's will attempt walk this back under $2.50 like they did last Thursday (and it was absolutely walked, the intraday chart looks like step stairs), have a trade trigger in at that price....hope it fills!

[umiak]

"In the current standard of care with head and neck tumors, we may systematically remove as many as 60 or more lymph nodes within the neck during a formal dissection procedure, a large number due to the likelihood that patients may have hidden cancer in the lymphatic system," said Stephen Y. Lai, M.D., Ph.D., FACS, Associate Professor, Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center. "The use of sentinel lymph node biopsy for selected patients with head and neck cancers is in evolution. These combined interim data, along with our initial clinical experience with Lymphoseek, suggest a very high level of accuracy in the identification and mapping of SLNs that may significantly improve the precision and practicality of SLN mapping procedures, and provide precision staging that may help direct post-surgical treatment. We look forward to developing the full potential of this technology for the appropriate patients," added Dr. Lai.

I would want my surgeon to have access to Lymphoseek.